PO.CL01.13 · 临床研究

利用 seqFISH 对神经母细胞瘤肿瘤微环境进行空间刻画

Spatial profiling of the neuroblastoma tumor microenvironment using seqFISH

海报缩略图:利用 seqFISH 对神经母细胞瘤肿瘤微环境进行空间刻画
编号 3964 展板 15 时间 4/20 02:00–05:00 区域 Section 49 主讲 Christopher Riccardi
分会场 Spatial Proteomics and Transcriptomics 2
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Christopher Riccardi1, Michal Polonsky2, Michael J. Zobel1, Rebekah Kennedy1, Melody Khoshneviszadeh1, Anya Zdanowicz1, Bruce Pawel1, James Amatruda1, Long Cai2, Shahab Asgharzadeh1

1Children's Hospital Los Angeles, Los Angeles, CA,2California Institute of Technology, Pasadena, CA

摘要 Abstract

中文摘要
背景:神经母细胞瘤是儿童期最常见的颅外实体肿瘤,高危疾病仍难以治疗。越来越多的证据表明,肿瘤细胞、免疫群体和基质成分之间的相互作用影响疾病进展和治疗反应。然而,这些群体在完整肿瘤内的空间组织和亚型多样性仍未明确界定。 方法:我们应用空间转录组平台 seqFISH,使用定制的 2,514 基因面板对来自七名患者新鲜冷冻肿瘤的八个感兴趣区域(ROI)进行分析,并使用商业化的 516 基因免疫肿瘤学面板对来自两个肿瘤的三个 ROI 进行分析。肿瘤标本涵盖一系列临床风险组,包括原发、转移、MYCN 扩增和治疗后状态。所有样本均使用 scVI Python 软件包进行分析和整合,这是一种深度生成模型,可从高维数据中提取潜在嵌入,同时减轻批次效应并保留生物学相关结构。为进行细胞身份分配,我们开发了一种新的联合分析算法,将 seqFISH 数据与 NBAtlas 单细胞 RNA-seq 参考数据集(61 名患者的 362,991 个细胞)整合,从而实现对主要神经母细胞瘤、免疫和基质谱系的初步映射,随后通过空间背景、邻近关系和标志性标志基因表达进行细化。CAF、TAM 和 T 细胞群体被单独重新整合以解析亚型结构,并使用空间统计方法鉴定出现频率高于随机预期的细胞类型关联。 结果:我们刻画了超过 450,000 个空间分辨的细胞,并通过 NBAtlas 指导的高置信度分配鉴定出主要细胞类型。神经母细胞瘤肿瘤细胞表现出与临床风险相关的增殖特征,与 NBAtlas 中观察到的模式相呼应。我们解析了多样的基质状态——包括血管、炎症、干扰素刺激、肌成纤维细胞和肿瘤样 CAF——并在原位区分了 M1 样和 M2 样 TAM 亚群。空间分析揭示了保守的邻域,包括 CD4⁺ 初始/中央记忆 T 细胞在炎症性 CAF 附近的富集,以及血管 CAF 与内皮细胞之间强烈的共定位。 结论:通过将 seqFISH 与大型神经母细胞瘤单细胞参考数据集整合,我们生成了神经母细胞瘤肿瘤微环境的详细空间图谱。这种组合方法能够更精细地鉴定细胞亚型,并揭示可能影响肿瘤行为和治疗易感性的可重复微环境结构。正在进行的工作包括扩大样本量、纳入空间拷贝数分析,以及将此框架应用于其他儿童实体肿瘤。
查看英文原文 English abstract
Background: Neuroblastoma is the most common extracranial solid tumor of childhood, and high-risk disease remains difficult to treat. Increasing evidence suggests that interactions among tumor cells, immune populations, and stromal elements influence progression and therapeutic response. However, the spatial organization and subtype diversity of these populations within intact tumors remain poorly defined. Methods: We applied seqFISH, a spatial transcriptomic platform, to eight regions of interest (ROIs) from fresh-frozen tumors of seven patients using a custom 2,514-gene panel, and to three ROIs from two tumors using a commercial 516-gene immuno-oncology panel. Tumor specimens represented a range of clinical risk groups and included primary, metastatic, MYCN-amplified, and post-therapy states. All samples were analyzed and integrated using the scVI Python package, a deep generative model that extracts latent embeddings from high-dimensional data while mitigating batch effects and preserving biologically relevant structure. To assign cell identities, we developed a novel joint-analysis algorithm that integrates seqFISH data with the NBAtlas single-cell RNA-seq reference (362,991 cells across 61 patients), enabling initial mapping of major neuroblastoma, immune, and stromal lineages, followed by refinement through spatial context, proximity relationships, and canonical marker gene expression. CAFs, TAMs, and T-cell populations were re-integrated separately to resolve subtype structure, and spatial statistics methods were used to identify cell-type associations occurring more frequently than expected by chance. Results: We profiled over 450,000 spatially resolved cells and identified major cell types with high-confidence NBAtlas-guided assignments. Neuroblastoma tumor cells displayed proliferative signatures associated with clinical risk, mirroring patterns observed in NBAtlas. We resolved diverse stromal states - including vascular, inflammatory, interferon-stimulated, myofibroblastic, and tumor-like CAFs - and distinguished M1- and M2-like TAM subsets in situ. Spatial analyses revealed conserved neighborhoods, including enrichment of CD4⁺ naïve/central-memory T cells adjacent to inflammatory CAFs and strong co-localization between vascular CAFs and endothelial cells. Conclusion: By integrating seqFISH with a large neuroblastoma single-cell reference, we generate a detailed spatial map of the neuroblastoma tumor microenvironment. This combined approach enables refined identification of cellular subtypes and reveals reproducible microenvironmental structures that may influence tumor behavior and therapeutic vulnerability. Ongoing efforts include expanding sample size, incorporating spatial copy-number analysis, and applying this framework to additional pediatric solid tumors.
利益披露 Disclosure
C. Riccardi, None.. M. Polonsky, None.. M. J. Zobel, None.. R. Kennedy, None.. M. Khoshneviszadeh, None.. A. Zdanowicz, None.. B. Pawel, None.. J. Amatruda, None. L. Cai, Spatial Genomics Inc. Other, co-Founder. S. Asgharzadeh, None.

← 返回 AACR 2026 检索